Aliquots
-
Immune cell activity and melanoma
The activity of a certain factor in immune cells is essential for an anti-tumor response, emphasizing the need to consider the effects of anti-cancer therapies on immune cells. Read MoreNov 6, 2014
-
Key to prostate cancer resistance
A combination of two types of therapy may be more effective in treating castration-resistant prostate cancer. Read MoreOct 29, 2014
-
Peptide quells “genomic storm”
A cell-penetrating peptide developed at Vanderbilt blocks the signaling pathways that lead to lethal shock caused by bacterial infection. Read MoreOct 28, 2014
-
Immune cells’ role in hypertension
Vanderbilt researchers have discovered that certain immune cells contribute to the development of hypertension, suggesting novel targets for treating the disease. Read MoreOct 24, 2014
-
New view of transporter dynamics
New insights to the workings of a protein that moves neurotransmitters across the nerve cell membrane could aid the design of more effective antidepressants. Read MoreOct 23, 2014
-
Antibiotics, fetal vessel defect linked
Certain antibiotics increase the risk of a congenital heart disorder called patency of the ductus arteriosis. Read MoreOct 15, 2014
-
Neuronal culprit in genetic disease
A particular neuronal cell population is involved in the pathogenesis of a rare neurological disorder, Vanderbilt researchers have discovered. Read MoreOct 14, 2014
-
Aspirin and allergies
Drugs such as aspirin and indomethacin may increase sensitivity to airborne allergens by suppressing production of the signaling molecule PGI2, which in turn may offer a new treatment for allergies. Read MoreOct 10, 2014
-
Long-range signaling to stem cells
The potential for long-range signaling factors – such as those identified in the current study – to regulate stem cell behaviors has implications in tumor progression and metastasis. Read MoreOct 9, 2014
-
Optical imaging in drug therapy screens
A non-invasive imaging tool could test potential cancer therapies quickly to personalize therapy for patients. Read MoreOct 1, 2014
-
Seizure mutation impairs receptor
Defects in the production of certain receptors are linked to the pathogenesis of genetic epilepsies and fever-induced seizures. Read MoreSep 30, 2014
-
Biomarker for diabetic eye disease
A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies. Read MoreSep 26, 2014
-
A path to sarcoidosis treatment
Vanderbilt investigators identify a new therapeutic target for the inflammatory lung disease sarcoidosis. Read MoreSep 25, 2014
-
Dioxin, fathers and preterm birth
Exposure of male mice to the pollutant dioxin causes preterm birth across multiple generations, suggesting that efforts to prevent preterm birth should include pre-conception interventions for dads. Read MoreSep 18, 2014
-
Patient-derived stem cells shed light on pulmonary hypertension
Stem cells derived from patients with pulmonary arterial hypertension provide a unique resource for studying the molecular defects that cause the disease and testing potential therapies. Read MoreSep 16, 2014
-
Schizophrenia ‘switches’ discovered
Drugs developed at Vanderbilt could provide a new way to treat schizophrenia in a personalized way. Read MoreSep 12, 2014
-
Bone healing therapy for NF1 fractures
A combination treatment delivered to the site of fractures may improve bone healing in patients with the genetic disease neurofibromatosis type-1. Read MoreSep 11, 2014
-
Aggressive bone cancers build more blood vessels
A subpopulation of bone cancer cells may be responsible for driving clinically aggressive behavior, suggesting new treatment options. Read MoreSep 3, 2014
-
Protein interaction protects against neurodegeneration
Two proteins interact to maintain selenium levels in the brain, and protect neurons from degeneration. Read MoreSep 2, 2014
-
Skin biopsy to diagnose depression?
It may be possible to use skin cells as biomarkers to diagnose and manage depression. Read MoreAug 29, 2014